Adverse events of unapproved drugs in Japan.
Miyakoshi
Shigesaburo
S
Kusumi
Eiji
E
Kodama
Yuko
Y
Narimatsu
Hiroto
H
Hamaki
Tamae
T
Matsumura
Tomoko
T
Kami
Masahiro
M
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D002986:Clinical Trials as Topic; D003257:Consumer Product Safety; D017277:Drug Approval; D004348:Drug Labeling; D033161:Government Regulation; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007564:Japan; D008389:Marketing of Health Services; D010353:Patient Education as Topic; D028701:Patient Rights; D018579:Patient Selection; D011719:Pyrazines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib